• Twitter
  • Twitter
  • Slideshare
  • logo Amatsigroup

      Preclinical Development Phase 1 Phase 2 Phase 3
COMPOUND APPLICATION TECHNOLOGY Lead
optimisation
Preclinical
development
     
P0304 Tablet Oral (conventional)
P0304 Capsule Oral (conventional)
P0201 Tablet Oral (conventional)
P0301 Capsule Oral (conventional)
P0303 Capsule Oral (conventional)
P0307 Capsule Oral (conventional)
P0102 Beads in capsule Oral (conventional)
P0103 Beads in capsule Oral (conventional)
P0303 Solubility enhancing liquid Oral (conventional)
P0305 Solubility enhacing liquid Oral (conventional)
P0305 Capsule Oral (conventional)
P0306 Capsule Oral (conventional)
P0304 Solubility enhacing liquid Oral (conventional)
P0501 Solubility enhacing liquid Oral (conventional)
P0801 Powder Oral (conventional)
P1201 Powder Oral (conventional)